Pharmaceutical care in transplantation: current challenges and future opportunities

Written by Nanomedicine

In this commentary, authors review the importance of highly effective immunosuppression to the filed of solid organ transplantation and highlight the future scientific advancement required to further improve transplant patients’ quality of life. The United Network for Organ Sharing, the nonprofit organization that contracts with the government to manage the country’s organ transplantation system, reports that over 750,000 transplants have been performed in the USA since 1988. Over 113,000 individuals are currently listed as candidates on waiting lists for organs. In 2016, just over 23,000 referrals to organ procurement organizations met criteria for eligible or imminent death per the Organ...

To view this content, please register now for access

It's completely free